Innovation in immuno-oncology, targeted cancer therapies, and precision oncology is reshaping the Cancer Treatment Market, positioning it for robust growth and enhanced market penetration in key geographies in 2024. North America remains the hub of oncology innovation, with robust R&D networks, oncology clinical trials, and strong reimbursement frameworks, while Asia Pacific is witnessing rapid growth due to rising healthcare spending and expanding access to cancer therapy drugs. India provides a notable example, where over 68 lakh cancer treatments worth more than ₹13,000 crore have been delivered under PM-JAY, with nearly 76% of beneficiaries from rural areas, reflecting how government-led initiatives are shaping regional demand and adoption of cancer care technologies.
Cancer Treatment overview
Published by MMR Statistics Research Team, Updated